Complete regression of xenografted breast tumors by dextran-based dual drug conjugates containing paclitaxel and docosahexaenoic acid

This study revealed that the dextran-based dual drug conjugates may represent an effective and innovative way to deliver anticancer agents to a variety of tumors.PMID:35779290 | DOI:10.1016/j.ejmech.2022.114567

Source: European Journal of Medicinal Chemistry - July 2, 2022 Category: Chemistry Authors: Shenxu Wang Jiaojiao Liu Hongshuai Lv Xiaoyan Huang Peng Dong Qi Wang Haotong Yang Si Wang Xiaohai Li Jinghua Hu Dandan Wang Shengnan Cao Liangyu Xie Yikang Shi Source Type: research